Curaleaf Holdings, Inc. (CURLF) is the 72nd largest of 300 Cannabis companies by market capitalisation, at 2.66 Bn, behind Alignment Healthcare, Inc. at 2.70 Bn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CURLF | Curaleaf Holdings, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 2.66 Bn | -22.42 | 2.03 | 2.56 Bn |
| 2 | TRLV | Trulieve Cannabis Corp. | primary | S-09 | Tobacco and Cannabis | SG-04 | 2.27 Bn | -4.80 | 1.99 | 1.94 Bn |
| 3 | GTBIF | Green Thumb Industries Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 1.71 Bn | 13.63 | 1.41 | 1.42 Bn |
| 4 | CRON | Cronos Group Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 1.18 Bn | 14.86 | 4.97 | 0.38 Bn |
| 5 | GLAS | Glass House Brands Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.67 Bn | -13.03 | 4.36 | 0.65 Bn |
| 6 | VREOF | Vireo Growth Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.55 Bn | -6.37 | 1.07 | 0.40 Bn |
| 7 | TLRY | Tilray Brands, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.47 Bn | -4.86 | 0.51 | 0.24 Bn |
| 8 | VRNO | Verano Holdings Corp. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.43 Bn | -1.68 | 0.52 | 0.35 Bn |
| 9 | CGC | Canopy Growth Corp | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.41 Bn | -3.27 | 1.20 | 0.16 Bn |
| 10 | SNDL | SNDL Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.36 Bn | -17.72 | 0.54 | 0.23 Bn |
| 11 | VFF | Village Farms International, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.34 Bn | 16.48 | 1.49 | 0.27 Bn |
| 12 | ACB | Aurora Cannabis Inc | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.22 Bn | -6.81 | 1.05 | 0.15 Bn |
| 13 | HITI | High Tide Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.21 Bn | -6.56 | 0.45 | 0.19 Bn |
| 14 | TSNDF | TerrAscend Corp. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.20 Bn | -5.37 | 0.76 | 0.16 Bn |
| 15 | OGI | Organigram Global Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.14 Bn | -5.89 | 0.72 | 0.14 Bn |
| 16 | JUSH | Jushi Holdings Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.11 Bn | -1.69 | 0.41 | 0.08 Bn |
| 17 | GRUSF | Grown Rogue International Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.11 Bn | 0.00 | 0.00 | 0.10 Bn |
| 18 | AAWH | Ascend Wellness Holdings, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.09 Bn | -0.82 | 0.19 | 0.03 Bn |
| 19 | CWBHF | Charlotte's Web Holdings, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.07 Bn | -1.96 | 1.44 | 0.05 Bn |
| 20 | LEEEF | Leef Brands Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.06 Bn | -12.11 | 1.59 | 0.05 Bn |
| 21 | RYM | RYTHM, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.05 Bn | -15.68 | 0.99 | 0.01 Bn |
| 22 | PLNH | Planet 13 Holdings Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.05 Bn | -0.74 | 0.49 | 0.03 Bn |
| 23 | MRMD | Marimed Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.03 Bn | -2.14 | 0.20 | 0.02 Bn |
| 24 | CXXIF | C21 Investments Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.03 Bn | 3.88 | 0.97 | 0.03 Bn |
| 25 | YCBD | cbdMD, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.01 Bn | -1.55 | 0.27 | 0.00 Bn |
| 26 | CVSI | CV Sciences, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.00 Bn | -2.28 | 0.33 | 0.00 Bn |
| 27 | BUDZ | Weed, Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.00 Bn | -1.22 | — | 0.00 Bn |
| 28 | IMCC | IM Cannabis Corp. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.00 Bn | -0.20 | 0.05 | 0.00 Bn |
| 29 | LIFD | Lftd Partners Inc. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.00 Bn | -0.05 | 0.04 | 0.00 Bn |
| 30 | AKAN | Akanda Corp. | primary | S-09 | Tobacco and Cannabis | SG-04 | 0.00 Bn | -0.09 | 0.84 | 0.00 Bn |
| 31 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 32 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 443.31 Bn | 70.19 | 6.89 | 436.74 Bn |
| 33 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.74 Bn | 115.10 | 5.48 | 357.60 Bn |
| 34 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 354.24 Bn | 23.76 | 0.79 | 322.77 Bn |
| 35 | PM | Philip Morris International Inc. | secondary | S-08 | Tobacco and Cannabis | SG-04 | 289.42 Bn | 24.00 | 6.80 | 283.42 Bn |
| 36 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.46 Bn | 9.25 | 3.88 | 258.77 Bn |
| 37 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 38 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 39 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 40 | CVS | CVS HEALTH Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 122.38 Bn | 25.05 | 0.29 | 108.42 Bn |
| 41 | HCA | HCA Healthcare, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 93.33 Bn | 11.91 | 1.20 | 92.32 Bn |
| 42 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.33 Bn | 11.23 | 0.98 | 44.95 Bn |
| 43 | HUM | Humana Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 48.22 Bn | 35.15 | 0.33 | 24.35 Bn |
| 44 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.79 Bn | -24.76 | — | 43.79 Bn |
| 45 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 46 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.70 Bn | 52.41 | 3.13 | 32.24 Bn |
| 47 | CNC | Centene Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 31.79 Bn | -6.23 | 0.16 | 4.73 Bn |
| 48 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 49 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.54 Bn | 14.41 | 1.39 | 27.44 Bn |
| 50 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 51 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.23 Bn | 15.65 | 4.34 | 20.69 Bn |
| 52 | THC | Tenet Healthcare Corp | secondary | H-13 | Healthcare Providers | HG-04 | 22.50 Bn | 10.04 | 1.03 | 20.33 Bn |
| 53 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 54 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 55 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.21 Bn | 11.62 | 0.92 | 15.46 Bn |
| 56 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 57 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.22 Bn | 16.17 | 3.31 | 13.60 Bn |
| 58 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | 16.98 | 6.00 | 13.78 Bn |
| 59 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.38 Bn | 40.38 | 4.09 | 13.77 Bn |
| 60 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 61 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.90 Bn | 10.22 | 0.85 | 11.21 Bn |
| 62 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.32 Bn | -37.78 | 107.81 | 10.63 Bn |
| 63 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.89 Bn | -70.84 | 14.02 | 10.57 Bn |
| 64 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.15 | 17.26 | 10.46 Bn |
| 65 | UHS | Universal Health Services Inc | secondary | H-13 | Healthcare Providers | HG-04 | 10.51 Bn | 6.89 | 0.58 | 10.37 Bn |
| 66 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.05 Bn | -26.35 | — | 9.29 Bn |
| 67 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.79 Bn | -13.35 | 144.68 | 8.62 Bn |
| 68 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 69 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 70 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.96 Bn | -47.63 | — | 8.96 Bn |
| 71 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.56 | 4.54 | 6.92 Bn |
| 72 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 73 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 74 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.87 | 10.50 | 6.09 Bn |
| 75 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.15 Bn | 0.08 | — | 6.15 Bn |
| 76 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 77 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.71 | 32.00 | 5.64 Bn |
| 78 | RDNT | RadNet, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 5.52 Bn | 286.90 | 2.43 | 4.79 Bn |
| 79 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 80 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.89 Bn | -17.03 | — | 4.89 Bn |
| 81 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 82 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.76 Bn | 12.50 | 4.18 | 3.80 Bn |
| 83 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.69 | — | 4.67 Bn |
| 84 | CON | Concentra Group Holdings Parent, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 4.28 Bn | 20.83 | 1.87 | 4.12 Bn |
| 85 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -11.83 | — | 4.18 Bn |
| 86 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.13 Bn | 11.63 | 3.10 | 3.91 Bn |
| 87 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | -7.94 | 1,126.80 | 4.06 Bn |
| 88 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.48 | — | 4.00 Bn |
| 89 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 90 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -45.13 | — | 3.80 Bn |
| 91 | OPCH | Option Care Health, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 3.62 Bn | 17.26 | 0.64 | 3.42 Bn |
| 92 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -76.58 | 5.93 | 3.14 Bn |
| 93 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 94 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.79 | 30.64 | 2.88 Bn |
| 95 | CRVL | Corvel Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 3.41 Bn | — | — | 3.06 Bn |
| 96 | WRBY | Warby Parker Inc. | secondary | D-10 | Apparel and Luxury | DG-04 | 3.03 Bn | 390.92 | 3.32 | 2.73 Bn |
| 97 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -10.96 | 593.06 | 2.44 Bn |
| 98 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.57 | 79.61 | 2.48 Bn |
| 99 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -10.83 | 394.49 | 2.81 Bn |
| 100 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -14.90 | 6.24 | 2.10 Bn |
| 101 | ALHC | Alignment Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.70 Bn | 66.36 | 0.59 | 2.00 Bn |
| 102 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.36 | — | 2.64 Bn |
| 103 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.54 | 0.06 | -3.19 Bn |
| 104 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -61.67 | — | 2.60 Bn |
| 105 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | -7.41 | — | 2.59 Bn |
| 106 | PRVA | Privia Health Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.57 Bn | 76.15 | 1.09 | 2.16 Bn |
| 107 | ACHC | Acadia Healthcare Company, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 2.57 Bn | -2.95 | 0.76 | 2.40 Bn |
| 108 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 109 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.71 | 3.10 | 2.07 Bn |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.50 | 2.51 | 1.60 Bn |
| 111 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 112 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -5.95 | 4.28 | 1.94 Bn |
| 113 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.11 | 13.44 | 2.28 Bn |
| 114 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -3.87 | — | 2.00 Bn |
| 115 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.18 Bn | -41.21 | — | 1.87 Bn |
| 116 | MD | Pediatrix Medical Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.15 Bn | 12.29 | 1.10 | 1.74 Bn |
| 117 | PGNY | Progyny, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.12 Bn | 27.02 | 1.62 | 1.89 Bn |
| 118 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.70 | 6.76 | 1.66 Bn |
| 119 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 2,033.16 | 2.03 Bn |
| 120 | ASTH | Astrana Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.87 Bn | 53.42 | 0.49 | 1.47 Bn |
| 121 | SGRY | Surgery Partners, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 1.82 Bn | 22.26 | 0.54 | 1.61 Bn |
| 122 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | 170.39 | 16.23 | 1.60 Bn |
| 123 | ARDT | Ardent Health, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.58 Bn | 9.35 | 0.25 | 0.85 Bn |
| 124 | AGL | agilon health, inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.55 Bn | -6.70 | 0.26 | 1.37 Bn |
| 125 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.91 | 3.01 | 0.97 Bn |
| 126 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 127 | HCSG | Healthcare Services Group Inc | secondary | I-27 | Business Services | IG-06 | 1.51 Bn | 12.26 | 0.81 | 1.34 Bn |
| 128 | INNV | InnovAge Holding Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 1.50 Bn | -96.74 | 1.59 | 1.37 Bn |
| 129 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 130 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 131 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.70 | — | 1.43 Bn |
| 132 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.67 | — | 1.42 Bn |
| 133 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 134 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | 82.16 | 36.50 | 1.40 Bn |
| 135 | EYE | National Vision Holdings, Inc. | secondary | D-36 | Retail | DG-10 | 1.36 Bn | 48.83 | 0.69 | 1.32 Bn |
| 136 | NUTX | Nutex Health Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.36 Bn | 4.98 | 1.60 | 1.15 Bn |
| 137 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.52 | 3.97 | 1.21 Bn |
| 138 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.77 | — | 1.02 Bn |
| 139 | USPH | U S Physical Therapy Inc /Nv | secondary | H-14 | Healthcare Providers | HG-04 | 1.17 Bn | 23.44 | 1.44 | 1.14 Bn |
| 140 | UTI | Universal Technical Institute Inc | secondary | D-28 | Consumer Services | DG-09 | 1.16 Bn | 33.93 | 1.32 | 0.99 Bn |
| 141 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -30.70 | 1.98 | 0.86 Bn |
| 142 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -5.32 | — | 1.09 Bn |
| 143 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.95 | 1.08 Bn |
| 144 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 145 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.03 | — | 0.92 Bn |
| 146 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 147 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -11.54 | — | 0.73 Bn |
| 148 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -48.72 | — | 0.91 Bn |
| 149 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.91 | 9.10 | 0.66 Bn |
| 150 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.89 | 95.78 | 0.79 Bn |
| 151 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 15.72 | 0.93 | 0.60 Bn |
| 152 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.42 | 3.04 | 0.54 Bn |
| 153 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.24 | 5.24 | 0.49 Bn |
| 154 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -38.15 | 5.90 | 0.65 Bn |
| 155 | WOOF | Petco Health & Wellness Company, Inc. | secondary | S-13 | Staples Retail | SG-06 | 0.70 Bn | 28.24 | 0.12 | 0.41 Bn |
| 156 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 157 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.19 | 11.84 | 0.54 Bn |
| 158 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.07 | 1.70 | 0.38 Bn |
| 159 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 160 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -340,055.90 | — | 0.60 Bn |
| 161 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,165.03 | 6.03 | 0.48 Bn |
| 162 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -16.41 | 1.78 | 0.52 Bn |
| 163 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 164 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -17.80 | — | 0.54 Bn |
| 165 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.37 | 334.91 | 0.41 Bn |
| 166 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.52 Bn | -13.14 | 2.07 | 0.48 Bn |
| 167 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.36 | 4.46 | 0.38 Bn |
| 168 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.41 | 22.27 | 0.22 Bn |
| 169 | EVH | Evolent Health, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.47 Bn | -0.92 | 0.22 | 0.33 Bn |
| 170 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 78.36 | 0.23 Bn |
| 171 | SRTA | Strata Critical Medical, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.45 Bn | 11.19 | 1.76 | 0.43 Bn |
| 172 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.99 | 28.37 | 0.25 Bn |
| 173 | MCTA | Charming Medical Ltd | secondary | D-29 | Consumer Services | DG-09 | 0.45 Bn | -42,242.59 | 92.66 | 0.44 Bn |
| 174 | SBC | SBC Medical Group Holdings Inc | secondary | H-14 | Healthcare Providers | HG-04 | 0.44 Bn | 11.72 | 2.53 | 0.26 Bn |
| 175 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 176 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.43 | — | 0.26 Bn |
| 177 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.86 | 11.34 | 0.42 Bn |
| 178 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -52.78 | — | 0.41 Bn |
| 179 | CYH | Community Health Systems Inc | secondary | H-13 | Healthcare Providers | HG-04 | 0.40 Bn | 2.40 | 0.03 | 0.25 Bn |
| 180 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.14 | 39.23 | 0.19 Bn |
| 181 | AUNA | Auna S.A. | secondary | H-13 | Healthcare Providers | HG-04 | 0.38 Bn | 3.80 | 0.08 | 0.23 Bn |
| 182 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 183 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 184 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.47 | 0.15 Bn |
| 185 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.28 | 7.49 | 0.27 Bn |
| 186 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.02 | — | 0.30 Bn |
| 187 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.67 | 0.38 | 0.15 Bn |
| 188 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 189 | TBI | TrueBlue, Inc. | secondary | I-25 | Business Services | IG-06 | 0.28 Bn | -4.86 | 0.16 | 0.25 Bn |
| 190 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -1.94 | — | 0.27 Bn |
| 191 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.70 | 1.18 | 0.10 Bn |
| 192 | INFU | InfuSystem Holdings, Inc | secondary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.60 | 1.70 | 0.24 Bn |
| 193 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 194 | STIM | Neuronetics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | -6.96 | 1.43 | 0.20 Bn |
| 195 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 196 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.33 | 7.32 | 0.21 Bn |
| 197 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.05 | — | 0.21 Bn |
| 198 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -55.91 | 3.00 | 0.18 Bn |
| 199 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.59 | — | 0.20 Bn |
| 200 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -38.89 | 8.50 | 0.20 Bn |
| 201 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.17 | 14.71 | 0.16 Bn |
| 202 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 203 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -29.09 | — | 0.19 Bn |
| 204 | AIRS | Airsculpt Technologies, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.19 Bn | -15.81 | 1.23 | 0.17 Bn |
| 205 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -1.42 | — | 0.12 Bn |
| 206 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 207 | NAKA | Nakamoto Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 0.16 Bn | -0.38 | 4.03 | 0.14 Bn |
| 208 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.19 | 7.19 | 0.15 Bn |
| 209 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.40 | 107.84 | 0.14 Bn |
| 210 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 1,788.24 | -0.04 Bn |
| 211 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.80 | — | 0.14 Bn |
| 212 | BMEA | Biomea Fusion, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.33 | — | 0.13 Bn |
| 213 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -5.99 | 36.76 | 0.10 Bn |
| 214 | JYNT | JOINT Corp | secondary | H-14 | Healthcare Providers | HG-04 | 0.12 Bn | 30.75 | 1.97 | 0.09 Bn |
| 215 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -4.22 | — | 0.10 Bn |
| 216 | VRCA | Verrica Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.48 | 3.60 | 0.10 Bn |
| 217 | AARD | Aardvark Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.55 | — | 0.03 Bn |
| 218 | TENX | Tenax Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.49 | — | 0.10 Bn |
| 219 | CPIX | Cumberland Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.86 | 3.05 | 0.09 Bn |
| 220 | SLQT | SelectQuote, Inc. | secondary | F-16 | Insurance | FG-04 | 0.09 Bn | -8.09 | 0.06 | 0.07 Bn |
| 221 | CGTX | Cognition Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.47 | — | 0.09 Bn |
| 222 | NTHI | Neonc Technologies Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.99 | — | 0.09 Bn |
| 223 | MNOV | Medicinova Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.67 | 100.93 | 0.09 Bn |
| 224 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.72 | — | 0.08 Bn |
| 225 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.57 | 0.06 Bn |
| 226 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.01 | 1.21 | -0.11 Bn |
| 227 | RGC | Regencell Bioscience Holdings Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.07 Bn |
| 228 | PMVP | PMV Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.20 | — | -0.01 Bn |
| 229 | PLRX | Pliant Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 230 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.07 Bn | -0.08 | 3.47 | 0.06 Bn |
| 231 | UPXI | Upexi, Inc. | secondary | T-59 | Fintech | TG-09 | 0.07 Bn | -0.28 | 2.59 | 0.06 Bn |
| 232 | BOLD | Boundless Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 233 | VERU | Veru Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 115.53 | — | 0.03 Bn |
| 234 | MYO | Myomo, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | — | — | 0.04 Bn |
| 235 | GOSS | Gossamer Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.30 | 0.96 | -0.01 Bn |
| 236 | RYOJ | rYojbaba Co., Ltd. | secondary | H-14 | Healthcare Providers | HG-04 | 0.05 Bn | -47.64 | 6.80 | 0.05 Bn |
| 237 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.87 | 3.83 | 0.05 Bn |
| 238 | KPTI | Karyopharm Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.25 | 0.33 | -0.02 Bn |
| 239 | ANVS | Annovis Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.95 | — | 0.05 Bn |
| 240 | CLNN | Clene Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.36 | 217.73 | 0.05 Bn |
| 241 | APRE | Aprea Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.41 | — | 0.04 Bn |
| 242 | BTMD | biote Corp. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.37 | 0.23 | 0.03 Bn |
| 243 | IXHL | Incannex Healthcare Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.84 | — | 0.04 Bn |
| 244 | GRCE | Grace Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.85 | — | 0.04 Bn |
| 245 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.72 | 4.79 | 0.03 Bn |
| 246 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.13 | -0.08 Bn |
| 247 | DCGO | DocGo Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.17 | 0.12 | 0.01 Bn |
| 248 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.04 Bn |
| 249 | UG | United Guardian Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.34 | 2.90 | 0.02 Bn |
| 250 | ACTU | Actuate Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.51 | — | 0.03 Bn |
| 251 | CPHI | China Pharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.01 | 8.02 | 0.03 Bn |
| 252 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -6.19 | 0.38 | 0.03 Bn |
| 253 | PIII | P3 Health Partners Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -0.11 | 0.02 | 0.01 Bn |
| 254 | NSRX | Nasus Pharma Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 255 | ETST | Earth Science Tech, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.72 | 0.02 Bn |
| 256 | CRVO | CervoMed Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.85 | 77.46 | 0.03 Bn |
| 257 | YARW | Yarrow Bioscience, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.20 | 50.30 | 0.00 Bn |
| 258 | BYSI | BeyondSpring Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -2.97 | — | 0.03 Bn |
| 259 | EUDA | EUDA Health Holdings Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -9.10 | 3.74 | 0.02 Bn |
| 260 | TXMD | TherapeuticsMD, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -132.69 | 7.51 | 0.02 Bn |
| 261 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | 0.40 | 0.00 Bn |
| 262 | ATOS | Atossa Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.72 | — | 0.02 Bn |
| 263 | SY | So-Young International Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -0.57 | 0.08 | -0.09 Bn |
| 264 | ALLR | Allarity Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.67 | 808.26 | 0.02 Bn |
| 265 | BFRI | Biofrontera Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.28 | 0.45 | 0.02 Bn |
| 266 | AAQL | Antiaging Quantum Living Inc. | secondary | T-47 | Internet Platforms | TG-08 | 0.02 Bn | -19.44 | 13.50 | 0.02 Bn |
| 267 | MIRA | Mira Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.56 | — | 0.01 Bn |
| 268 | TANAF | Tian'an Technology Group Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | — | 37.78 | 0.02 Bn |
| 269 | CCM | Concord Medical Services Holdings Ltd | secondary | H-13 | Healthcare Providers | HG-04 | 0.02 Bn | -1.45 | 0.29 | -0.02 Bn |
| 270 | TVRD | Tvardi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.67 | — | 0.02 Bn |
| 271 | KPRX | Kiora Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.41 | — | 0.02 Bn |
| 272 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.17 | 0.02 Bn |
| 273 | LDDD | Longduoduo Co Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 274 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.02 Bn | -1.23 | — | 0.01 Bn |
| 275 | KPEA | Kun Peng International Ltd. | secondary | D-32 | Retail | DG-10 | 0.01 Bn | -14.13 | 24.95 | 0.01 Bn |
| 276 | ANEB | Anebulo Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 277 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.01 Bn | -2.05 | — | 0.01 Bn |
| 278 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.05 | — | 0.01 Bn |
| 279 | PFHO | Pacific Health Care Organization Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 0.01 Bn | 13.73 | 2.09 | 0.00 Bn |
| 280 | ADIA | Adia Nutrition, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 69.62 | 0.01 Bn |
| 281 | INTI | Inhibitor Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 282 | AMS | American Shared Hospital Services | secondary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -3.77 | 0.33 | 0.00 Bn |
| 283 | XWEL | XWELL, Inc. | secondary | D-29 | Consumer Services | DG-09 | 0.01 Bn | -0.24 | 0.28 | 0.00 Bn |
| 284 | CALC | CalciMedica, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.38 | -9.36 | -0.01 Bn |
| 285 | BMGL | Basel Medical Group Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | 10.57 | — | 0.01 Bn |
| 286 | VPRB | VPR Brands, LP. | secondary | S-08 | Tobacco and Cannabis | SG-04 | 0.01 Bn | 5.64 | 2.50 | 0.00 Bn |
| 287 | HLYK | HealthLynked Corp | secondary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -1.32 | 4.82 | 0.01 Bn |
| 288 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.74 | — | 0.01 Bn |
| 289 | ADXN | Addex Therapeutics Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 290 | ACXP | Acurx Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 291 | CURX | Curanex Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.00 Bn |
| 292 | TRAW | Traws Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 293 | PCSA | Processa Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.41 | — | 0.01 Bn |
| 294 | PULM | Pulmatrix, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.32 | — | 0.01 Bn |
| 295 | INM | InMed Pharmaceuticals Inc. | secondary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.66 | — | 0.00 Bn |
| 296 | LFST | LifeStance Health Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.09 | 0.00 | -0.22 Bn |
| 297 | STLNW | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.14 | 0.01 | -0.04 Bn |
| 298 | TPST | Tempest Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.25 | — | 0.00 Bn |
| 299 | TCRT | Alaunos Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.93 | 1,256.38 | 0.00 Bn |
| 300 | BICX | BioCorRx Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |